|
| related topics |
| {interest, director, officer} |
| {product, liability, claim} |
| {product, candidate, development} |
| {product, market, service} |
| {stock, price, share} |
| {stock, price, operating} |
| {control, financial, internal} |
| {personnel, key, retain} |
| {property, intellectual, protect} |
| {competitive, industry, competition} |
| {debt, indebtedness, cash} |
|
|
***You should read the following risk factors
carefully before purchasing our common stock. ***
RISKS RELATING TO OUR BUSINESS
We have a limited operating history upon which an evaluation of our prospects can be made. For that reason, it would be difficult for a potential investor to judge our prospects for success.
We are competing against well established sellers of alternative treatment supplies in a unique manner.
We may not be able to compete effectively against our competitors, which could force us to curtail or cease business operations.
There are no conclusive studies regarding the medical benefits using the Pen
We may face product liability for the product we sell.
coverage could harm our business.
Our product is subject to obsolescence, which could reduce our sales significantly
Adverse publicity with respect to alternative acupuncture methods and related products may force us to curtail or cease our business operations
We have no manufacturing capabilities and we are dependent upon United appointed manufacturers to manufacture our products.
Because we have no proprietary rights, others can provide products substantially equivalent to ours.
We are dependent on the services of our President and the loss of his services could have a material adverse effect on our ability to carry on business.
Our shareholders may not be able to enforce U.S. civil liabilities claims.
If we do not receive shareholder loans we may be unable to continue meeting our minimum funding requirements.
RISKS RELATING TO OUR COMMON STOCK
Broker-dealers may be discouraged from effecting transactions in our shares because they are considered penny stocks and are subject to the penny stock rules.
Our stock is substantially controlled by one shareholder for the foreseeable future and as a result, that shareholder will be able to control our overall direction.
Full 10-K form ▸
|
|
| related documents |
| 1043894--4/15/2009--ENVIRO_VORAXIAL_TECHNOLOGY_INC |
| 1371534--11/12/2009--Vita_Spirits_Corp. |
| 862668--10/12/2010--ESCALON_MEDICAL_CORP |
| 1068874--10/15/2007--IMPLANT_SCIENCES_CORP |
| 1104280--12/3/2010--SANGUI_BIOTECH_INTERNATIONAL_INC |
| 1009356--3/15/2007--SALIX_PHARMACEUTICALS_LTD |
| 816284--2/20/2008--CELGENE_CORP_/DE/ |
| 1364544--4/2/2009--Craft_College_Inc |
| 1009356--3/16/2006--SALIX_PHARMACEUTICALS_LTD |
| 1410708--10/28/2008--Emo_Capital_Corp. |
| 841543--3/30/2010--GEN_RX_INC |
| 841543--3/31/2009--GEN_RX_INC |
| 911649--4/2/2007--STRATEGIC_DIAGNOSTICS_INC/DE/ |
| 862668--10/13/2009--ESCALON_MEDICAL_CORP |
| 1103092--4/15/2009--BALSAM_VENTURES_INC |
| 810084--4/2/2007--BIOJECT_MEDICAL_TECHNOLOGIES_INC |
| 1006195--3/15/2007--MATRIXX_INITIATIVES_INC |
| 1025771--3/30/2010--CHASE_PACKAGING_CORP |
| 1301843--10/21/2009--Quantum_Ventures_Inc. |
| 1342916--1/22/2009--American_Bonanza_Resources_Corp. |
| 1006195--6/8/2009--MATRIXX_INITIATIVES_INC |
| 1423586--2/26/2010--Quadra_Projects_Inc. |
| 1416299--11/12/2009--Avatar_Ventures_Corp. |
| 882873--9/21/2009--UROLOGIX_INC |
| 1025362--3/31/2010--GOLDEN_QUEEN_MINING_CO_LTD |
| 1025315--3/31/2006--24HOLDINGS_INC |
| 1375685--1/22/2009--BTHC_X_INC |
| 1125918--11/9/2009--Euoko_Group_Inc. |
| 855683--3/17/2009--MILESTONE_SCIENTIFIC_INC/NJ |
| 922330--7/30/2010--REGI_U_S_INC |
|